电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

小鼠 anti-人 Ig (Chain lambda), (Light Chain) Antibody (PE)

FACS Monoclonal NaM79-8E6 IgG1 PE
产品编号 ABIN1108012
发货至: 中国

Quick Overview for 小鼠 anti-人 Ig (Chain lambda), (Light Chain) Antibody (PE) (ABIN1108012)

抗原

Ig

克隆类型

  • 123
  • 95
单克隆

标记

  • 54
  • 25
  • 23
  • 22
  • 18
  • 14
  • 12
  • 10
  • 5
  • 4
  • 4
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
PE

应用范围

  • 173
  • 138
  • 101
  • 69
  • 57
  • 26
  • 22
  • 12
  • 12
  • 7
  • 7
  • 6
  • 4
  • 4
  • 2
  • 1
  • 1
  • 1
Flow Cytometry (FACS)

克隆位点

NaM79-8E6

亚型

IgG1
  • 抗原表位

    • 80
    • 78
    • 63
    • 38
    • 4
    • 2
    • 1
    Chain lambda, Light Chain

    适用

    • 118
    • 63
    • 20
    • 18
    • 9
    • 4
    • 4
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1

    宿主

    • 102
    • 77
    • 39
    • 18
    • 3
    • 1
    • 1
    小鼠

    纯化方法

    Affinity chromatography
  • 应用备注

    Optimal working dilution should be determined by the investigator.

    限制

    仅限研究用
  • 缓冲液

    0.01 M sodium phosphate, 0.15 M NaCl, pH 7.3, 0.2 % BSA, 0.09 % sodium azide

    储存液

    Sodium azide

    注意事项

    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    储存条件

    4 °C

    储存方法

    Store the antibody undiluted at 2-8 °C. Fluorochrome labelled product is photosensitive and should be protected from light.
  • 抗原

    Ig

    别名

    Immunoglobulin

    背景

    Kappa light chains of human immunoglobulins occur in 50-70 % of normal human B lymphocytes while lambda light chains are expressed in 30-50 % of these cells. Abnormal expression of kappa and lambda light chains occur in leukemia. Anti-kappa and anti-lambda antibodies are frequently used in combination with CD19 or CD138 for the detection of light chains of surface immunoglobulin on normal and neoplastic B cells.
You are here:
Chat with us!